Could a light cap save infant brains after cardiac arrest?

NCT ID NCT07556939

Not yet recruiting Disease control Sponsor: Mitovation, Inc Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This early study tests a special cap that shines near-infrared light on the heads of infants who have had a cardiac arrest in the hospital. The light is meant to reduce brain injury caused when blood flow returns. The trial will include 30 infants with heart disease and will check if the cap is safe and easy to use in the intensive care unit.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: near-infrared light delivered via a special cap (LUCID device)
What this could lead to: If it works, this could lead to a new bedside treatment that reduces brain damage in infants after cardiac arrest.
What could go wrong: This is a very early safety study with only 30 infants, so it is not designed to prove the device works. The treatment is experimental and may not improve outcomes.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ACQUIRED OR CONGENITAL HEART DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

heart disorder post-cardiac arrest syndrome ischemia reperfusion injury prevention target

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

POST CARDIAC ARREST BRAIN INJURY REPERFUSION INJURY

Contacts and locations

Locations

Children's Hospital of Michigan (Detroit)

Detroit, Michigan, 48201, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.